Panelists discuss how diuretics serve as necessary “bailout therapy” for volume management in heart failure but should not substitute for guideline-directed medical therapy, with emerging evidence ...
Panelists discuss how heart failure creates a massive economic burden of approximately $30 billion annually (expected to reach $70 billion to $80 billion by 2030), driven by hospitalizations, ...
Larry Allen, MD, MHS, and Kenneth B Margulies, MD, discuss HF management for American Heart Month and Heart Failure Awareness Week. Advances in heart failure research and management have led to ...
Aaron M Wolfson, MD, and Sarah J Goodlin, MD, discuss nonpharmacologic interventions for patients with heart failure. Despite significant advances in the pharmacologic management of individuals with ...